Melasma
☆ AI Dermatology — Free Service
I dtorthaí 2022 Stiftung Warentest ón nGearmáin, ní raibh sástacht na dtomhaltóirí le ModelDerm ach beagán níos ísle ná mar a bhí le comhairliúchán teileamhíochaine íoctha.
I dtorthaí 2022 Stiftung Warentest ón nGearmáin, ní raibh sástacht na dtomhaltóirí le ModelDerm ach beagán níos ísle ná mar a bhí le comhairliúchán teileamhíochaine íoctha.
Is coinníoll coitianta é a fheictear i mná na hÁise sna 40idí luatha. Tá an lót ciorclach sa ghrianghraf níos gaire le lentigo ná le melasma.
relevance score : -100.0%
ReferencesTranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. This systematic review searched major databases for relevant publications to March 2016. Eleven studies with 667 participants were included. Pooled data from tranexamic acid-only observational studies with pre- and post-treatment Melasma Area and Severity Index (MASI) showed a decrease of 1.60 in MASI after treat?ment with tranexamic acid. The addition of tranexamic acid to routine treatment modalities resulted in a further decrease in MASI of 0.94. These results support the efficacy and safety of tranexamic acid, either alone or as an adjuvant to routine treatment modalities for melasma.
Le déanaí, tá tóir ar léasair low-fluence Q-switched Nd:YAG (LFQSNY) chun melasma a chóireáil, go háirithe san Áise. Bhí sé dúshlánach staidéir éagsúla a achoimriú, ach is cosúil go ginearálta go bhfuil LFQSNY éifeachtach agus sábháilte le haghaidh melasma i gcomparáid le teiripí traidisiúnta. Mar sin féin, tuairiscíodh roinnt cásanna de hypopigmentation mottled mar fo-éifeacht LFQSNY, b'fhéidir mar gheall ar fhuinneamh léasair ard. Is féidir hyperpigmentation ó athlasadh a bheith mar thoradh ar úsáid ionsaitheach LFQSNY, go háirithe i toin dorcha craiceann.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Is minic a aimsítear fadhbanna líocha i gcúram príomhúil. I measc na gcineálacha coitianta de neamhoird hyperpigmentation tá post‑inflammatory hyperpigmentation, melasma, sunspots, freckles, agus café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Ní féidir melasma a réiteach le cóireáil léasair ar feadh tréimhse áirithe, toisc gur galar é a dhéantar a chóiriú go leanúnach. Cuidíonn aigéad tranexamic acid le laghdú ar an pigmentation.
○ Cóireáil
I roinnt tíortha (m.sh. an tSeapáin, an Chóiré), tá aigéad tranexamic acid béil ar fáil thar an gcuntar agus tá sé éifeachtach. D'fhéadfadh go mbeadh an uachtar melasma le aigéad tranexamic acid agus aigéad azelaic ina chuidiú go páirteach.
Féadfar hidroquinone a úsáid go topach chun hipearpigmentation a chóireáil, ach chuir an FDA stop leis na táirgí thar an gcuntar a raibh hidróquinone iontu ó 2020.
#Tranexamic acid [TRANSINO]
#Laser toning technique (low fluence QS1064 laser)
#Triluma